Evidence map›Paper›PMID 10098735›Full record

ArticleBritish journal of cancer1999

Mutation analysis of the Fanconi anaemia A gene in breast tumours with loss of heterozygosity at 16q24.3.

A M Cleton-Jansen, E W Moerland, J C Pronk, C G van Berkel, S Apostolou, J Crawford, A Savoia, A D Auerbach, C G Mathew, D F Callen and 1 more

Open access · hybridAbstract read
In one paragraph

Article in British journal of cancer, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 4 countries.

A M Cleton-JansenDepartment of Pathology, Leiden University Medical Center, The Netherlands.
E W Moerland
J C Pronk
C G van Berkel
S Apostolou
J Crawford
A Savoia
A D Auerbach
C G Mathew
D F Callen
C J Cornelisse
Leiden University Medical Center · NLUniversity of Amsterdam · NLCasa Sollievo della Sofferenza · ITGuy's Hospital · GBRockefeller University · US

Funding

FANCONI ANEMIA--HETEROGENEITY AND CARRIER DETECTIONR37HL032987 · NHLBI · ROCKEFELLER UNIVERSITY · PI AUERBACH, ARLEEN D · 1997 to 2007
$3.2M
FANCONI ANEMIA: HETEROGENEITY AND CARRIER DETECTIONR01HL032987 · NHLBI · ROCKEFELLER UNIVERSITY · PI AUERBACH, ARLEEN D · 1985 to 1996
–
NHLBI NIH HHS HL32987
6 · The paper itself

Abstract

The recently identified Fanconi anaemia A (FAA) gene is located on chromosomal band 16q24.3 within a region that has been frequently reported to show loss of heterozygosity (LOH) in breast cancer. FAA mutation analysis of 19 breast tumours with specific LOH at 16q24.3 was performed. Single-stranded conformational polymorphism (SSCP) analysis on cDNA and genomic DNA, and Southern blotting failed to identify any tumour-specific mutations. Five polymorphisms were identified, but frequencies of occurrence did not deviate from those in a normal control population. Therefore, the FAA gene is not the gene targeted by LOH at 16q24.3 in breast cancer. Another tumour suppressor gene in this chromosomal region remains to be identified.

Indexed as

Cell Cycle ProteinsDNA-Binding ProteinsLoss of HeterozygosityNuclear ProteinsBreast NeoplasmsChromosomes, Human, Pair 16DNA Mutational AnalysisFanconi Anemia Complementation Group ProteinsFemaleGenes, Tumor SuppressorHumansPolymorphism, Single-Stranded ConformationalProteinsCell Cycle ProteinsDNA-Binding ProteinsFanconi Anemia Complementation Group ProteinsNuclear ProteinsProteins

Identifiers

PMID10098735
PMCPMC2362253
OpenAlexW2033872759

What OpenQuestion holds

Texttitle and abstract
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.